 | • レポートコード：MRC2Q12-19108 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、C型肝炎ウイルス治療薬の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にC型肝炎ウイルス治療薬のグローバル市場のxxx％を占める「抗ウイルス薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 C型肝炎ウイルス治療薬の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのC型肝炎ウイルス治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 C型肝炎ウイルス治療薬のグローバル主要プレイヤーには、Gilead、Merck、AbbVie、J&J、Bristol-Myers Squibb、Kawin、Glaxosmithkline、Novartis、Rocheなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 C型肝炎ウイルス治療薬市場は、種類と用途によって区分されます。世界のC型肝炎ウイルス治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 抗ウイルス薬、免疫調節薬、その他 【用途別セグメント】 病院、家庭用 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - C型肝炎ウイルス治療薬製品概要 - 種類別市場（抗ウイルス薬、免疫調節薬、その他） - 用途別市場（病院、家庭用） - 調査の目的 ・エグゼクティブサマリー - 世界のC型肝炎ウイルス治療薬販売量予測2017-2028 - 世界のC型肝炎ウイルス治療薬売上予測2017-2028 - C型肝炎ウイルス治療薬の地域別販売量 - C型肝炎ウイルス治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別C型肝炎ウイルス治療薬販売量 - 主要メーカー別C型肝炎ウイルス治療薬売上 - 主要メーカー別C型肝炎ウイルス治療薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（抗ウイルス薬、免疫調節薬、その他） - C型肝炎ウイルス治療薬の種類別販売量 - C型肝炎ウイルス治療薬の種類別売上 - C型肝炎ウイルス治療薬の種類別価格 ・用途別市場規模（病院、家庭用） - C型肝炎ウイルス治療薬の用途別販売量 - C型肝炎ウイルス治療薬の用途別売上 - C型肝炎ウイルス治療薬の用途別価格 ・北米市場 - 北米のC型肝炎ウイルス治療薬市場規模（種類別、用途別） - 主要国別のC型肝炎ウイルス治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのC型肝炎ウイルス治療薬市場規模（種類別、用途別） - 主要国別のC型肝炎ウイルス治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のC型肝炎ウイルス治療薬市場規模（種類別、用途別） - 主要国別のC型肝炎ウイルス治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のC型肝炎ウイルス治療薬市場規模（種類別、用途別） - 主要国別のC型肝炎ウイルス治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのC型肝炎ウイルス治療薬市場規模（種類別、用途別） - 主要国別のC型肝炎ウイルス治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Gilead、Merck、AbbVie、J&J、Bristol-Myers Squibb、Kawin、Glaxosmithkline、Novartis、Roche ・産業チェーン及び販売チャネル分析 - C型肝炎ウイルス治療薬の産業チェーン分析 - C型肝炎ウイルス治療薬の原材料 - C型肝炎ウイルス治療薬の生産プロセス - C型肝炎ウイルス治療薬の販売及びマーケティング - C型肝炎ウイルス治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - C型肝炎ウイルス治療薬の産業動向 - C型肝炎ウイルス治療薬のマーケットドライバー - C型肝炎ウイルス治療薬の課題 - C型肝炎ウイルス治療薬の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Hepatitis C Virus Drugs estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Hepatitis C Virus Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Hepatitis C Virus Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Hepatitis C Virus Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Hepatitis C Virus Drugs include Gilead, Merck, AbbVie, J&J, Bristol-Myers Squibb, Kawin, Glaxosmithkline, Novartis and Roche, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Hepatitis C Virus Drugs companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Hepatitis C Virus Drugs market. Further, it explains the major drivers and regional dynamics of the global Hepatitis C Virus Drugs market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Gilead
Merck
AbbVie
J&J
Bristol-Myers Squibb
Kawin
Glaxosmithkline
Novartis
Roche
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Hepatitis C Virus Drugs Segment by Type
Anti-Viral Drugs
Immuno-modulators
Others
Hepatitis C Virus Drugs Segment by Application
Hospitals
Home
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Hepatitis C Virus Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Hepatitis C Virus Drugs market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Hepatitis C Virus Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hepatitis C Virus Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hepatitis C Virus Drugs revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Hepatitis C Virus Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Hepatitis C Virus Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Gilead, Merck, AbbVie, J&J, Bristol-Myers Squibb, Kawin, Glaxosmithkline, Novartis and Roche, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Hepatitis C Virus Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hepatitis C Virus Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis C Virus Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis C Virus Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anti-Viral Drugs
1.2.3 Immuno-modulators
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hepatitis C Virus Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Home
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis C Virus Drugs Market Perspective (2017-2028)
2.2 Hepatitis C Virus Drugs Growth Trends by Region
2.2.1 Hepatitis C Virus Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Hepatitis C Virus Drugs Historic Market Size by Region (2017-2022)
2.2.3 Hepatitis C Virus Drugs Forecasted Market Size by Region (2023-2028)
2.3 Hepatitis C Virus Drugs Market Dynamics
2.3.1 Hepatitis C Virus Drugs Industry Trends
2.3.2 Hepatitis C Virus Drugs Market Drivers
2.3.3 Hepatitis C Virus Drugs Market Challenges
2.3.4 Hepatitis C Virus Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis C Virus Drugs Players by Revenue
3.1.1 Global Top Hepatitis C Virus Drugs Players by Revenue (2017-2022)
3.1.2 Global Hepatitis C Virus Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Hepatitis C Virus Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hepatitis C Virus Drugs Revenue
3.4 Global Hepatitis C Virus Drugs Market Concentration Ratio
3.4.1 Global Hepatitis C Virus Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Virus Drugs Revenue in 2021
3.5 Hepatitis C Virus Drugs Key Players Head office and Area Served
3.6 Key Players Hepatitis C Virus Drugs Product Solution and Service
3.7 Date of Enter into Hepatitis C Virus Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis C Virus Drugs Breakdown Data by Type
4.1 Global Hepatitis C Virus Drugs Historic Market Size by Type (2017-2022)
4.2 Global Hepatitis C Virus Drugs Forecasted Market Size by Type (2023-2028)
5 Hepatitis C Virus Drugs Breakdown Data by Application
5.1 Global Hepatitis C Virus Drugs Historic Market Size by Application (2017-2022)
5.2 Global Hepatitis C Virus Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hepatitis C Virus Drugs Market Size (2017-2028)
6.2 North America Hepatitis C Virus Drugs Market Size by Type
6.2.1 North America Hepatitis C Virus Drugs Market Size by Type (2017-2022)
6.2.2 North America Hepatitis C Virus Drugs Market Size by Type (2023-2028)
6.2.3 North America Hepatitis C Virus Drugs Market Share by Type (2017-2028)
6.3 North America Hepatitis C Virus Drugs Market Size by Application
6.3.1 North America Hepatitis C Virus Drugs Market Size by Application (2017-2022)
6.3.2 North America Hepatitis C Virus Drugs Market Size by Application (2023-2028)
6.3.3 North America Hepatitis C Virus Drugs Market Share by Application (2017-2028)
6.4 North America Hepatitis C Virus Drugs Market Size by Country
6.4.1 North America Hepatitis C Virus Drugs Market Size by Country (2017-2022)
6.4.2 North America Hepatitis C Virus Drugs Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hepatitis C Virus Drugs Market Size (2017-2028)
7.2 Europe Hepatitis C Virus Drugs Market Size by Type
7.2.1 Europe Hepatitis C Virus Drugs Market Size by Type (2017-2022)
7.2.2 Europe Hepatitis C Virus Drugs Market Size by Type (2023-2028)
7.2.3 Europe Hepatitis C Virus Drugs Market Share by Type (2017-2028)
7.3 Europe Hepatitis C Virus Drugs Market Size by Application
7.3.1 Europe Hepatitis C Virus Drugs Market Size by Application (2017-2022)
7.3.2 Europe Hepatitis C Virus Drugs Market Size by Application (2023-2028)
7.3.3 Europe Hepatitis C Virus Drugs Market Share by Application (2017-2028)
7.4 Europe Hepatitis C Virus Drugs Market Size by Country
7.4.1 Europe Hepatitis C Virus Drugs Market Size by Country (2017-2022)
7.4.2 Europe Hepatitis C Virus Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis C Virus Drugs Market Size (2017-2028)
8.2 Asia-Pacific Hepatitis C Virus Drugs Market Size by Type
8.2.1 Asia-Pacific Hepatitis C Virus Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Hepatitis C Virus Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Hepatitis C Virus Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Hepatitis C Virus Drugs Market Size by Application
8.3.1 Asia-Pacific Hepatitis C Virus Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Hepatitis C Virus Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Hepatitis C Virus Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Hepatitis C Virus Drugs Market Size by Region
8.4.1 Asia-Pacific Hepatitis C Virus Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Hepatitis C Virus Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hepatitis C Virus Drugs Market Size (2017-2028)
9.2 Latin America Hepatitis C Virus Drugs Market Size by Type
9.2.1 Latin America Hepatitis C Virus Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Hepatitis C Virus Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Hepatitis C Virus Drugs Market Share by Type (2017-2028)
9.3 Latin America Hepatitis C Virus Drugs Market Size by Application
9.3.1 Latin America Hepatitis C Virus Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Hepatitis C Virus Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Hepatitis C Virus Drugs Market Share by Application (2017-2028)
9.4 Latin America Hepatitis C Virus Drugs Market Size by Country
9.4.1 Latin America Hepatitis C Virus Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Hepatitis C Virus Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis C Virus Drugs Market Size (2017-2028)
10.2 Middle East & Africa Hepatitis C Virus Drugs Market Size by Type
10.2.1 Middle East & Africa Hepatitis C Virus Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Hepatitis C Virus Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Hepatitis C Virus Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Hepatitis C Virus Drugs Market Size by Application
10.3.1 Middle East & Africa Hepatitis C Virus Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Hepatitis C Virus Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Hepatitis C Virus Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Hepatitis C Virus Drugs Market Size by Country
10.4.1 Middle East & Africa Hepatitis C Virus Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Hepatitis C Virus Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Gilead
11.1.1 Gilead Company Details
11.1.2 Gilead Business Overview
11.1.3 Gilead Hepatitis C Virus Drugs Introduction
11.1.4 Gilead Revenue in Hepatitis C Virus Drugs Business (2017-2022)
11.1.5 Gilead Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Hepatitis C Virus Drugs Introduction
11.2.4 Merck Revenue in Hepatitis C Virus Drugs Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Hepatitis C Virus Drugs Introduction
11.3.4 AbbVie Revenue in Hepatitis C Virus Drugs Business (2017-2022)
11.3.5 AbbVie Recent Developments
11.4 J&J
11.4.1 J&J Company Details
11.4.2 J&J Business Overview
11.4.3 J&J Hepatitis C Virus Drugs Introduction
11.4.4 J&J Revenue in Hepatitis C Virus Drugs Business (2017-2022)
11.4.5 J&J Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Hepatitis C Virus Drugs Introduction
11.5.4 Bristol-Myers Squibb Revenue in Hepatitis C Virus Drugs Business (2017-2022)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Kawin
11.6.1 Kawin Company Details
11.6.2 Kawin Business Overview
11.6.3 Kawin Hepatitis C Virus Drugs Introduction
11.6.4 Kawin Revenue in Hepatitis C Virus Drugs Business (2017-2022)
11.6.5 Kawin Recent Developments
11.7 Glaxosmithkline
11.7.1 Glaxosmithkline Company Details
11.7.2 Glaxosmithkline Business Overview
11.7.3 Glaxosmithkline Hepatitis C Virus Drugs Introduction
11.7.4 Glaxosmithkline Revenue in Hepatitis C Virus Drugs Business (2017-2022)
11.7.5 Glaxosmithkline Recent Developments
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Hepatitis C Virus Drugs Introduction
11.8.4 Novartis Revenue in Hepatitis C Virus Drugs Business (2017-2022)
11.8.5 Novartis Recent Developments
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Hepatitis C Virus Drugs Introduction
11.9.4 Roche Revenue in Hepatitis C Virus Drugs Business (2017-2022)
11.9.5 Roche Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Hepatitis C Virus Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Anti-Viral Drugs
Table 3. Key Players of Immuno-modulators
Table 4. Key Players of Others
Table 5. Global Hepatitis C Virus Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Hepatitis C Virus Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Hepatitis C Virus Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Hepatitis C Virus Drugs Market Share by Region (2017-2022)
Table 9. Global Hepatitis C Virus Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Hepatitis C Virus Drugs Market Share by Region (2023-2028)
Table 11. Hepatitis C Virus Drugs Market Trends
Table 12. Hepatitis C Virus Drugs Market Drivers
Table 13. Hepatitis C Virus Drugs Market Challenges
Table 14. Hepatitis C Virus Drugs Market Restraints
Table 15. Global Hepatitis C Virus Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Hepatitis C Virus Drugs Revenue Share by Players (2017-2022)
Table 17. Global Top Hepatitis C Virus Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus Drugs as of 2021)
Table 18. Ranking of Global Top Hepatitis C Virus Drugs Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Hepatitis C Virus Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hepatitis C Virus Drugs Product Solution and Service
Table 22. Date of Enter into Hepatitis C Virus Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hepatitis C Virus Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Hepatitis C Virus Drugs Revenue Market Share by Type (2017-2022)
Table 26. Global Hepatitis C Virus Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Hepatitis C Virus Drugs Revenue Market Share by Type (2023-2028)
Table 28. Global Hepatitis C Virus Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Hepatitis C Virus Drugs Revenue Share by Application (2017-2022)
Table 30. Global Hepatitis C Virus Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Hepatitis C Virus Drugs Revenue Share by Application (2023-2028)
Table 32. North America Hepatitis C Virus Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Hepatitis C Virus Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Hepatitis C Virus Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Hepatitis C Virus Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Hepatitis C Virus Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Hepatitis C Virus Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Hepatitis C Virus Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Hepatitis C Virus Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Hepatitis C Virus Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Hepatitis C Virus Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Hepatitis C Virus Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Hepatitis C Virus Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Hepatitis C Virus Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Hepatitis C Virus Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Hepatitis C Virus Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Hepatitis C Virus Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Hepatitis C Virus Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Hepatitis C Virus Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Hepatitis C Virus Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Hepatitis C Virus Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Hepatitis C Virus Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Hepatitis C Virus Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Hepatitis C Virus Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Hepatitis C Virus Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Hepatitis C Virus Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Hepatitis C Virus Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Hepatitis C Virus Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Hepatitis C Virus Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Hepatitis C Virus Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Hepatitis C Virus Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 62. Gilead Company Details
Table 63. Gilead Business Overview
Table 64. Gilead Hepatitis C Virus Drugs Product
Table 65. Gilead Revenue in Hepatitis C Virus Drugs Business (2017-2022) & (US$ Million)
Table 66. Gilead Recent Developments
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Hepatitis C Virus Drugs Product
Table 70. Merck Revenue in Hepatitis C Virus Drugs Business (2017-2022) & (US$ Million)
Table 71. Merck Recent Developments
Table 72. AbbVie Company Details
Table 73. AbbVie Business Overview
Table 74. AbbVie Hepatitis C Virus Drugs Product
Table 75. AbbVie Revenue in Hepatitis C Virus Drugs Business (2017-2022) & (US$ Million)
Table 76. AbbVie Recent Developments
Table 77. J&J Company Details
Table 78. J&J Business Overview
Table 79. J&J Hepatitis C Virus Drugs Product
Table 80. J&J Revenue in Hepatitis C Virus Drugs Business (2017-2022) & (US$ Million)
Table 81. J&J Recent Developments
Table 82. Bristol-Myers Squibb Company Details
Table 83. Bristol-Myers Squibb Business Overview
Table 84. Bristol-Myers Squibb Hepatitis C Virus Drugs Product
Table 85. Bristol-Myers Squibb Revenue in Hepatitis C Virus Drugs Business (2017-2022) & (US$ Million)
Table 86. Bristol-Myers Squibb Recent Developments
Table 87. Kawin Company Details
Table 88. Kawin Business Overview
Table 89. Kawin Hepatitis C Virus Drugs Product
Table 90. Kawin Revenue in Hepatitis C Virus Drugs Business (2017-2022) & (US$ Million)
Table 91. Kawin Recent Developments
Table 92. Glaxosmithkline Company Details
Table 93. Glaxosmithkline Business Overview
Table 94. Glaxosmithkline Hepatitis C Virus Drugs Product
Table 95. Glaxosmithkline Revenue in Hepatitis C Virus Drugs Business (2017-2022) & (US$ Million)
Table 96. Glaxosmithkline Recent Developments
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Hepatitis C Virus Drugs Product
Table 100. Novartis Revenue in Hepatitis C Virus Drugs Business (2017-2022) & (US$ Million)
Table 101. Novartis Recent Developments
Table 102. Roche Company Details
Table 103. Roche Business Overview
Table 104. Roche Hepatitis C Virus Drugs Product
Table 105. Roche Revenue in Hepatitis C Virus Drugs Business (2017-2022) & (US$ Million)
Table 106. Roche Recent Developments
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis C Virus Drugs Market Share by Type: 2021 VS 2028
Figure 2. Anti-Viral Drugs Features
Figure 3. Immuno-modulators Features
Figure 4. Others Features
Figure 5. Global Hepatitis C Virus Drugs Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Home Case Studies
Figure 8. Hepatitis C Virus Drugs Report Years Considered
Figure 9. Global Hepatitis C Virus Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Hepatitis C Virus Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Hepatitis C Virus Drugs Market Share by Region: 2021 VS 2028
Figure 12. Global Hepatitis C Virus Drugs Market Share by Players in 2021
Figure 13. Global Top Hepatitis C Virus Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus Drugs as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Hepatitis C Virus Drugs Revenue in 2021
Figure 15. North America Hepatitis C Virus Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Hepatitis C Virus Drugs Market Size Market Share by Type (2017-2028)
Figure 17. North America Hepatitis C Virus Drugs Market Size Market Share by Application (2017-2028)
Figure 18. North America Hepatitis C Virus Drugs Market Size Share by Country (2017-2028)
Figure 19. United States Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Hepatitis C Virus Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Hepatitis C Virus Drugs Market Size Market Share by Type (2017-2028)
Figure 23. Europe Hepatitis C Virus Drugs Market Size Market Share by Application (2017-2028)
Figure 24. Europe Hepatitis C Virus Drugs Market Size Share by Country (2017-2028)
Figure 25. Germany Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Hepatitis C Virus Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Hepatitis C Virus Drugs Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Hepatitis C Virus Drugs Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Hepatitis C Virus Drugs Market Size Share by Region (2017-2028)
Figure 35. China Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Hepatitis C Virus Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Hepatitis C Virus Drugs Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Hepatitis C Virus Drugs Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Hepatitis C Virus Drugs Market Size Share by Country (2017-2028)
Figure 45. Mexico Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Hepatitis C Virus Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Hepatitis C Virus Drugs Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Hepatitis C Virus Drugs Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Hepatitis C Virus Drugs Market Size Share by Country (2017-2028)
Figure 51. Turkey Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Hepatitis C Virus Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Gilead Revenue Growth Rate in Hepatitis C Virus Drugs Business (2017-2022)
Figure 55. Merck Revenue Growth Rate in Hepatitis C Virus Drugs Business (2017-2022)
Figure 56. AbbVie Revenue Growth Rate in Hepatitis C Virus Drugs Business (2017-2022)
Figure 57. J&J Revenue Growth Rate in Hepatitis C Virus Drugs Business (2017-2022)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis C Virus Drugs Business (2017-2022)
Figure 59. Kawin Revenue Growth Rate in Hepatitis C Virus Drugs Business (2017-2022)
Figure 60. Glaxosmithkline Revenue Growth Rate in Hepatitis C Virus Drugs Business (2017-2022)
Figure 61. Novartis Revenue Growth Rate in Hepatitis C Virus Drugs Business (2017-2022)
Figure 62. Roche Revenue Growth Rate in Hepatitis C Virus Drugs Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed